Vai al contenuto
  • Home
  • Who we are
    • Vision
    • Management Team
    • Board
      • Directors
      • Observers
    • Career
  • Clinical
    • Clinical Need
    • Clinical Studies
    • Publications & Scientific Presentations
  • The CorFlow Solution
    • Our Technology
    • Voice of the Customer
  • News
    • Press Releases
  • Contact Us
  • Home
  • Who we are
    • Vision
    • Management Team
    • Board
      • Directors
      • Observers
    • Career
  • Clinical
    • Clinical Need
    • Clinical Studies
    • Publications & Scientific Presentations
  • The CorFlow Solution
    • Our Technology
    • Voice of the Customer
  • News
    • Press Releases
  • Contact Us
  • Press Releases
  • Press Releases

Scientific Presentations

Marzo 27, 2023

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Read More »

Publications

Marzo 27, 2023

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Read More »

Press Releases

Dicembre 16, 2022

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Read More »

CorFlow is developing a medical device that will be the first to diagnose MVO in real-time during PCI and serve as a treatment platform in the cath lab.

Twitter Linkedin
Who we are
  • Vision
  • Team
  • Career
Clinical
  • Clinical Need
  • Clinical Studies
  • Publication & Scientific Presentations
News
  • Press releases
Our Office
  • +41 41 399 18 00
  • CorFlow Therapeutics AG Neuhofstrasse 5A 6340 Baar, Switzerland
  • contact@corflow.ch

The CoFI-System is not approved in the United States of America.  It is an investigational device limited by federal law to investigational use and is not available for commercial distribution.

VAT:CHE 320.873.257 MWST

© 2026 Corflow. All Rights Reserved.

Cookie Policy | Privacy Policy | Site Map | Impressum